| Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 1.1K |
| Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 1.1K |
| CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016 | Neuro-Oncology | 2019 | 944 |
| Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 782 |
| Ageing as a risk factor for neurodegenerative disease | Nature Reviews Neurology | 2019 | 634 |
| Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11) | Pain | 2019 | 624 |
| MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation | NeuroImage | 2019 | 563 |
| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies | Lancet Neurology, The | 2019 | 562 |
| The neuropathological diagnosis of Alzheimer's disease | Molecular Neurodegeneration | 2019 | 554 |
| Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 480 |
| Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report | Brain | 2019 | 454 |
| The prevalence of MS in the United States: A population-based estimate using health claims data | Neurology | 2019 | 433 |
| Multiple sclerosis - a review | European Journal of Neurology | 2019 | 422 |
| Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 407 |
| Stroke in China: advances and challenges in epidemiology, prevention, and management | Lancet Neurology, The | 2019 | 403 |
| A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease | Nature Reviews Neurology | 2019 | 387 |
| Alzheimer's disease drug development pipeline: 2019 | Alzheimer's and Dementia: Translational Research and Clinical Interventions | 2019 | 378 |
| Small vessel disease: mechanisms and clinical implications | Lancet Neurology, The | 2019 | 372 |
| Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review | Movement Disorders | 2019 | 357 |
| Neuroinflammation: friend and foe for ischemic stroke | Journal of Neuroinflammation | 2019 | 344 |
| Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies | Nature Reviews Neurology | 2019 | 322 |
| Deep brain stimulation: current challenges and future directions | Nature Reviews Neurology | 2019 | 320 |
| Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study | Brain | 2019 | 303 |
| Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage? | Stroke | 2019 | 303 |
| Lead-DBS v2: Towards a comprehensive pipeline for deep brain stimulation imaging | NeuroImage | 2019 | 292 |
